Accounting for its prominent role in mediating sterile inflammation and its relation to detrimental outcome , HMGB1 measured 1 h after weaning from CPB would serve as a useful biomarker for accurate risk stratification in cardiac surgical patients and may guide tailored anti - inflammatory therapy .